Moving her2-low breast cancer predictive and prognostic data from clinical trials into the real world

HIGHLIGHTS

• who: HER and collaborators from the University of Naples Federico II, Italy have published the paper: Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world, in the Journal: (JOURNAL) of 30/05/2021
• what: For this study, the authors analyzed 444 women with baseline HER2-negative breast cancer based on IHC and ISH results . The authors report that 68% of HER2-low tumors are also HR-positive, which is consistent with prior results in the literature ranging from 64% to 88% (Denkert et_al, 2021; Schettini et_al, 2021). The . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.